ROVI CM - Contract manufacturing Services for injectable and solid forms. FDA-approved and GMP-certified.
Manufacturing / Testing / Packaging
Annual capacity of 250 million prefilled syringes, 50 million vials, 3 billion tablets, 200 million hard capsules and 30 million sachets.
Manufacturing / testing / packaging and storage
16 packaging line have been installed including high speed lines and very flexible lines for customized presentations providing capability for Alu-Alu, PVC-Alu, PVDC-Alu
No minimum batch size
Blister or aluminum pouches
High tech vision system, cartooning, labeling, marketing, overwrapping and casepacking capability for each packaging line
Capsules blistering also possible.
Integrated storage capability through our sizeable warehouse (9,000 pallets) which includes a cold room at 2 to 8 ºC (400 pallets).
High performance liquid chromatography (HPLC)
Atomic absorption spectroscopy
Near infra-red spectroscopy
Fourier transform IR spectroscopy
Six Sigma, Lean Manufacturing, 5S, Visual Management and QMS (Quality Management system) to ensure reliable and consistent quality as well as compliance with global regulatory requirements.
Development of Bemiparin (API)
Active pharmaceutical ingredient (API) manufacturing
ROVI manufactures the active substance Bemiparin in a manufacturing plant located in Granada with a surface area of 4.822 m2. In this facility, ROVI manufactures all the active substance necessary for its own products based on Bemiparin.
Finished product manufacturing
Furthermore, ROVI has a plant in Madrid for the manufacture of low volume injectables by means of aseptic filling or terminal sterilization, with an approximate surface area of 3,310 m2 and an injectables annual capacity of 220 million units. In this site the finished product with Bemiparin is manufactured as API and is distributed in more than 52 countries (among others: Italy, Greece, Austria, Russia, Czech Republic, Turkey, Middle East countries, Latin America, North Africa and Asia).
At ROVI we are conscious of the contribution of our products to the health progress but also we want to give response to certain social demands with regard to the impacts of our activities both in our employees and in the Environment.
We consider the Quality, the Safety and Health protection of our employees and the Environmental Protection as the three strategic pillars that support all our activities and we consider they are essential to be taken into account in the achievement of our targets.
All ROVI activities are developed according to the Good Manufacturing Practices and its performance is audited by the Spanish Agency of Medicines and Health Products.
In addition, as a result of the commitment we have with quality, ROVI is certificated according to ISO 9001:2008 and to ISO 13485:2003 "Medical devices. Quality management systems. Requirements for regulatory purposes"
At ROVI we are sure that the protection of the environment where our business is developed, is the only way to carry out a sustainable, lasting, integrated into the society and economically profitable activity.
At ROVI we are sure that our employees are the most important resources that we have. Therefore, we have introduced a Security and Health management system, according to OHSAS 18001:2007, which allows to eliminate, to minimize and/or to control labour risks of the workforce and other parts and to apply constant improvements.
Corporate Social Responsibility is the way to manage companies businesses considering the impact of all the aspects that their activities generate on customers, employees, shareholders, local communities, enviroment and society in general. Likewise